CompletedNot Applicable

Cervical Carious Lesions Restored With Calcium Silicate Based Cement (Biodentine) Compared With Glass-ionomer Cement

28 participantsStarted 2015-01-03

Plain-language summary

This study will test if applying calcium silicate cements (Biodentine) to restore cervical carious lesions might adversely affect the gingival health in comparison with conventionally used tooth colored material (GIC)

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. good general health;
✓. good oral hygiene; and
✓. age range 18-60 years old.
✓. current smokers;
✓. pregnant females;
✓. or patient with periodontal diseases; and
✓. those who had a history of poorly controlled diabetes, liver disease, malignancy, radiotherapy.

Exclusion criteria

✕. Pregnant women
✕. Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
✕. Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
✕. Complicated medical history (\>4 concurrent treatment for systemic diseases)
✕. Lesion \>1mm below the gum line

What they're measuring

Changes in Gingival index around Cervical Carious Lesions Restored with Calcium Silicate Based Cement (Biodentine™) Compared with Glass-Ionomer Cement;

Timeframe: 6 months

Changes in Plaque accumulation around Cervical Carious Lesions Restored with Calcium

Timeframe: 6 months

Trial details

NCT IDNCT03418246

SponsorJordan University of Science and Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-06-30

View on ClinicalTrials.gov More Gingivitis trials